Download the full-sized PDF
Permanent link (DOI): https://doi.org/10.7939/R3PC2TP3Z
This file is in the following communities:
|Agricultural, Food and Nutritional Science, Department of|
This file is in the following collections:
|Journal Articles (Agricultural, Food and Nutritional Science)|
Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome Open Access
- Author or creator
Nelson, Randy C.
Reaney, Martin J.
Curtis, Jonathan M.
Vine, Donna F.
Field, Catherine J.
Proctor, Spencer D.
- Additional contributors
Intestinal Inflammatory Diseases
- Type of item
- Journal Article (Published)
Vaccenic acid (VA), the predominant ruminant-derived trans fat in the food chain, ameliorates hyperlipidemia, yet mechanisms remain elusive. We investigated whether VA could influence tissue endocannabinoids (ECs) by altering the availability of their biosynthetic precursor, arachidonic acid (AA), in membrane phospholipids (PLs). JCR:LA-cp rats were assigned to a control diet with or without VA (1% w/w), cis-9, trans-11 conjugated linoleic acid (CLA) (1% w/w) or VA+CLA (1% + 0.5% w/w) for 8 weeks. VA reduced the EC, 2-arachidonoylglycerol (2-AG), in the liver and visceral adipose tissue (VAT) relative to control diet (P < 0.001), but did not change AA in tissue PLs. There was no additive effect of combining VA+CLA on 2-AG relative to VA alone (P > 0.05). Interestingly, VA increased jejunal concentrations of anandamide and those of the noncannabinoid signaling molecules, oleoylethanolamide and palmitoylethanolamide, relative to control diet (P < 0.05). This was consistent with a lower jejunal protein abundance (but not activity) of their degrading enzyme, fatty acid amide hydrolase, as well as the mRNA expression of TNFα and interleukin 1β (P < 0.05). The ability of VA to reduce 2-AG in the liver and VAT provides a potential mechanistic explanation to alleviate ectopic lipid accumulation. The opposing regulation of ECs and other noncannabinoid lipid signaling molecules by VA suggests an activation of benefit via the EC system in the intestine.
- Date created
- License information
- Attribution 3.0 Unported
- Citation for previous publication
Jacome-Sosa, M., Vacca, C., Mangat, R., Diane, A., Nelson, R. C., Reaney, M. J., Shen, J., Curtis, J. M., Vine, D. F., Field, C. J., Igarash, M., Piomelli, D., Banni, S., & Proctor, S. D. (2016). Vaccenic acid suppresses intestinal inflammation by increasing the endocannabinoid anandamide and non-cannabinoid signaling molecules in a rat model of the metabolic syndrome. Journal of Lipid Research, 57(4), 638-649. http://dx.doi.org/10.1194/jlr.M066308
- Link to related item
- Date Uploaded
- Date Modified
- Audit Status
- Audits have not yet been run on this file.
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 1464030
Last modified: 2017:09:06 16:31:03-06:00
Original checksum: 286390bed83ee731b80b59015c1624e6
Well formed: true
File title: Vaccenic acid suppresses intestinal inflammation by increasing anandamide and related N-acylethanolamines in the JCR:LA-cp rat[S]
File author: 7823
Page count: 12